As I understand it, the cost for the first product will be booked to revenue (and most likely cashflow) this half - it is just the profit share that doesn't get booked as revenue until 1H18? So there should at least be a bit of an indication in the next report as to what the product is worth.
Ann: Generics Sales Update, page-5
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $51.55M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $14.60K | 126.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 121011 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 88205 | 5 |
View Market Depth
| Last trade - 14.49pm 02/09/2024 (20 minute delay) ? |
| IDT (ASX) Chart |